삼성서울병원

Ko En

Hematology-Oncology Im, Young Hyuck M.D

Expertise
Breast cancer, medical treatment, clinical & translational research for breast cancer
Treament Schedule 04 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical Education

1994~1996 Ph.D. in Medicine Seoul National University, Korea
1991~1993 Master in Medicine Seoul National University, Korea
1980~1984 Bachelor in Medicine College of Medicine, Seoul National University, Korea

Post-Graduate Training

Fellowship   1991~1992 Division of Hematology/Oncology, Seoul National University Hospital, Korea
Residency   1989~1991 Department of Internal Medicine, Seoul National University Hospital, Korea
Internship   1987~1988 Seoul National University Hospital, Korea

Professional Appointments

2010~Present Professor Division of Hematology/Oncology, Sungkyunkwan University School of Medicine
2020~2022 Executive Vice President Medical Affairs, Sungkyunkwan University School of Medicine
2015~2020 Executive Vice President Research Institute for Future Medicine, Samsung Medical Center
2011~2014 Director Clinical Research Institute, Research Institute for Future Medicine, Samsung Medical Center
2011~2013 Chair Division of Hematology/Oncology, Samsung Medical Center
2011~2013 Associate Director Samsung Comprehensive Cancer Center, Samsung Medical Center
2010~2011 Director Research planning & strategy, Office of Biomedical Research, Samsung Medical Center
2005~2009 Director Breast Cancer Center, Samsung Medical Center
2004~2010 Associate professor Division of Hematology/Oncology, Sungkyunkwan University School of Medicine
2000~2004 Assisstant professor Division of Hematology/Oncology, Sungkyunkwan University School of Medicine
1997~2000 Research Fellow National Cancer Institute, National Institute of Health(NIH), USA
1992~1997 Section Chief Section of Hematology/Oncology II, Korea Cancer Center Hospital

Professional Memberships

2015~Present Member European Society of Medical Oncology(ESMO)
2016~Present Member American Association for Cancer Research(AACR)
1996~Present Member American Society of Clinical Oncology(ASCO)
2006~Present Member Korean Society of Medical Oncology(KSMO)
2002~Present Member Korean Cancer Association(KCA)
2001~Present Member Korea Cancer Study Group(KCSG)
2016~2018 Chair Board of Directors, Korean Society of Medical Oncology(KSMO)
2010~2014 Chair Education Committee, Korean Association for Clinical Oncology(KACO)
2007~2011 Chair Breast Cancer Committee, Korea Cancer Study Group(KCSG)

Selected Publications

  • FRONT ONCOL 2021 10.3389/fonc.2021.596364 Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry Kim1, JY; Lee, YS; Yu, J; Park, Y; Lee, SK; Lee, M; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kang, M; Im, YH
    View PubMed
  • J CLIN ONCOL 2021 10.1200/JCO.20.01204 Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up Piccart1, M; Procter, M; Fumagalli, D; de Azambuja, E; Clark, E; Ewer, MS; Restuccia, E; Jerusalem, G; Dent, S; Reaby, L; Bonnefoi, H; Krop, I; Liu, TW; Pienkowski, T; Toi, M; Wilcken, N; Andersson, M; Im, YH; Tseng, LM; Lueck, HJ; Colleoni, M; Monturus, E; Sicoe, M; Guillaume, S; Bines, J; Gelber, RD; Viale, G; Thomssen, C
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.653243 The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort Study Lee1, K; Sim, SH; Kang, EJ; Seo, JH; Chae, H; Lee, KS; Kim, JY; Ahn, JS; Im, YH; Park, S; Park, YH; Park, IH
    View PubMed
  • BREAST CANCER RES TREAT 2021 10.1007/s10549-021-06173-z Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES Im1, YH; Karabulut, B; Lee, KS; Park, BW; Adhav, A; Cinkir, HY; Abdel-Razeq, H; Chang, YC; Aksoy, S; Im, SA; Jeong, J; Chae, Y; Bowles, J; Slimane, K; Xue, HL; Kim, SB
    View PubMed
  • DIAGNOSTICS 2021 10.3390/diagnostics11020370 Local Laboratory Testing of Germline BRCA Mutations vs. Myriad: A Single-Institution Experience in Korea Hong1, J; Lee, J; Kwon, M; Kim, JY; Kim, JW; Ahn, JS; Im, YH; Park, YH
    View PubMed